Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma

R. S. Stein, J. P. Greer, S. Goodman, S. J. Brandt, D. S. Morgan, W. R. Macon, T. L. McCurley, S. N. Wolff

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Between 9/86 and 6/98, 22 patients with relapsed or refractory high grade lymphoma received intensified preparative therapy and underwent autologous transplantation at a single institution. Two intensified preparative regimens were used - cyclophosphamide, etoposide, total body irradiation (CY-VP-TBI) (N=17) and cyclophosphamide, BCNU, etoposide (CBV) (N=5). For all patients undergoing autologous transplantation, 5 year actuarial survival (S) and 5 year event free survival (EFS) were only 18% ± 8%. Treatment related mortality was 14% overall but only 8% in patients receiving G-CSF or GM-CSF. Survival was significantly inferior to the survival observed in a concurrent series of patients with intermediate grade lymphoma, 34% ± 6%, p<.05. Using high dose therapy in conjunction with autologous transplantation at the time of relapse may not be as valuable a strategy in high-grade lymphoma as in intermediate grade lymphoma although most studies combine the two disorders. Alternative strategies for the use of transplantation in high grade lymphoma, such as the use of transplantation as consolidation therapy, need to be investigated.

Original languageEnglish (US)
Pages (from-to)521-528
Number of pages8
JournalLeukemia and Lymphoma
Volume40
Issue number5-6
StatePublished - 2001
Externally publishedYes

Fingerprint

Salvage Therapy
Autologous Transplantation
Non-Hodgkin's Lymphoma
Etoposide
Granulocyte-Macrophage Colony-Stimulating Factor
Cyclophosphamide
Survival
Transplantation
Carmustine
Whole-Body Irradiation
Granulocyte Colony-Stimulating Factor
Therapeutics
Disease-Free Survival
Recurrence
Mortality

Keywords

  • Autologous
  • High-grade
  • Lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Stein, R. S., Greer, J. P., Goodman, S., Brandt, S. J., Morgan, D. S., Macon, W. R., ... Wolff, S. N. (2001). Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma. Leukemia and Lymphoma, 40(5-6), 521-528.

Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma. / Stein, R. S.; Greer, J. P.; Goodman, S.; Brandt, S. J.; Morgan, D. S.; Macon, W. R.; McCurley, T. L.; Wolff, S. N.

In: Leukemia and Lymphoma, Vol. 40, No. 5-6, 2001, p. 521-528.

Research output: Contribution to journalArticle

Stein, RS, Greer, JP, Goodman, S, Brandt, SJ, Morgan, DS, Macon, WR, McCurley, TL & Wolff, SN 2001, 'Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma', Leukemia and Lymphoma, vol. 40, no. 5-6, pp. 521-528.
Stein, R. S. ; Greer, J. P. ; Goodman, S. ; Brandt, S. J. ; Morgan, D. S. ; Macon, W. R. ; McCurley, T. L. ; Wolff, S. N. / Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma. In: Leukemia and Lymphoma. 2001 ; Vol. 40, No. 5-6. pp. 521-528.
@article{bafd9d22969a4ae88a1e260e456a0f69,
title = "Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma",
abstract = "Between 9/86 and 6/98, 22 patients with relapsed or refractory high grade lymphoma received intensified preparative therapy and underwent autologous transplantation at a single institution. Two intensified preparative regimens were used - cyclophosphamide, etoposide, total body irradiation (CY-VP-TBI) (N=17) and cyclophosphamide, BCNU, etoposide (CBV) (N=5). For all patients undergoing autologous transplantation, 5 year actuarial survival (S) and 5 year event free survival (EFS) were only 18{\%} ± 8{\%}. Treatment related mortality was 14{\%} overall but only 8{\%} in patients receiving G-CSF or GM-CSF. Survival was significantly inferior to the survival observed in a concurrent series of patients with intermediate grade lymphoma, 34{\%} ± 6{\%}, p<.05. Using high dose therapy in conjunction with autologous transplantation at the time of relapse may not be as valuable a strategy in high-grade lymphoma as in intermediate grade lymphoma although most studies combine the two disorders. Alternative strategies for the use of transplantation in high grade lymphoma, such as the use of transplantation as consolidation therapy, need to be investigated.",
keywords = "Autologous, High-grade, Lymphoma",
author = "Stein, {R. S.} and Greer, {J. P.} and S. Goodman and Brandt, {S. J.} and Morgan, {D. S.} and Macon, {W. R.} and McCurley, {T. L.} and Wolff, {S. N.}",
year = "2001",
language = "English (US)",
volume = "40",
pages = "521--528",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "5-6",

}

TY - JOUR

T1 - Limited efficacy of intensified preparative regimens and autologous transplantation as salvage therapy in high grade non-Hodgkin's lymphoma

AU - Stein, R. S.

AU - Greer, J. P.

AU - Goodman, S.

AU - Brandt, S. J.

AU - Morgan, D. S.

AU - Macon, W. R.

AU - McCurley, T. L.

AU - Wolff, S. N.

PY - 2001

Y1 - 2001

N2 - Between 9/86 and 6/98, 22 patients with relapsed or refractory high grade lymphoma received intensified preparative therapy and underwent autologous transplantation at a single institution. Two intensified preparative regimens were used - cyclophosphamide, etoposide, total body irradiation (CY-VP-TBI) (N=17) and cyclophosphamide, BCNU, etoposide (CBV) (N=5). For all patients undergoing autologous transplantation, 5 year actuarial survival (S) and 5 year event free survival (EFS) were only 18% ± 8%. Treatment related mortality was 14% overall but only 8% in patients receiving G-CSF or GM-CSF. Survival was significantly inferior to the survival observed in a concurrent series of patients with intermediate grade lymphoma, 34% ± 6%, p<.05. Using high dose therapy in conjunction with autologous transplantation at the time of relapse may not be as valuable a strategy in high-grade lymphoma as in intermediate grade lymphoma although most studies combine the two disorders. Alternative strategies for the use of transplantation in high grade lymphoma, such as the use of transplantation as consolidation therapy, need to be investigated.

AB - Between 9/86 and 6/98, 22 patients with relapsed or refractory high grade lymphoma received intensified preparative therapy and underwent autologous transplantation at a single institution. Two intensified preparative regimens were used - cyclophosphamide, etoposide, total body irradiation (CY-VP-TBI) (N=17) and cyclophosphamide, BCNU, etoposide (CBV) (N=5). For all patients undergoing autologous transplantation, 5 year actuarial survival (S) and 5 year event free survival (EFS) were only 18% ± 8%. Treatment related mortality was 14% overall but only 8% in patients receiving G-CSF or GM-CSF. Survival was significantly inferior to the survival observed in a concurrent series of patients with intermediate grade lymphoma, 34% ± 6%, p<.05. Using high dose therapy in conjunction with autologous transplantation at the time of relapse may not be as valuable a strategy in high-grade lymphoma as in intermediate grade lymphoma although most studies combine the two disorders. Alternative strategies for the use of transplantation in high grade lymphoma, such as the use of transplantation as consolidation therapy, need to be investigated.

KW - Autologous

KW - High-grade

KW - Lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0035051546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035051546&partnerID=8YFLogxK

M3 - Article

C2 - 11426525

AN - SCOPUS:0035051546

VL - 40

SP - 521

EP - 528

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 5-6

ER -